Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes

NCT03818581 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Insomnia
Sleep Disorder
Inflammation

Interventions

DRUG: Suvorexant
OTHER: Placebo

Sponsor

Massachusetts General Hospital